Beta-adrenoceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states
- PMID: 1680321
- PMCID: PMC1151384
- DOI: 10.1042/bj2780587
Beta-adrenoceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states
Abstract
1. The actions of the beta-adrenoceptor agonist isoprenaline on glucose and glycogen metabolism, in the presence of various concentrations of insulin, were investigated in isolated soleus muscle preparations taken from eu-, hyper- and hypothyroid rats. 2. Hyperthyroidism, induced by 3,3',5-tri-iodo-D-thyronine (T3) administration for 5 days, increased the rate of lactate formation and suppressed the rate of glycogen synthesis in soleus muscle in response to isoprenaline, even in the presence of physiological or supraphysiological insulin concentrations. 3. Hypothyroidism, induced by administration of 6-n-propyl-2-thiouracil for 4 weeks, decreased the rate of isoprenaline-stimulated lactate formation at all insulin concentrations, but significantly decreased the responsiveness of lactate formation only at low insulin concentrations. In the presence of 100 or 10,000 mu-units of insulin/ml, the ability of isoprenaline to suppress the rate of glycogen synthesis was markedly impaired (inhibition at 100 mu-units of insulin/ml and 1 micro-M-isoprenaline: eu- 72.6 +/- 2.9%; hypo-41.0 +/- 2.1%; P less than 0.001). 4. Hyperthyroidism had no effect on the number or affinity of beta-adrenoceptors, defined by 125I-pindolol binding, or beta-adrenoceptor- or forskolin-stimulated adenylate cyclase activity in membrane preparations of gastrocnemius muscle, whereas hypothyroidism increased the beta-adrenoceptor density and decreased the beta-adrenoceptor-stimulated adenylate cyclase activity, without affecting the receptor affinity or forskolin-stimulated adenylate cyclase activity. 5. It is concluded that there is a complex interplay between insulin, catecholamines and thyroid hormones to regulate skeletal-muscle glucose metabolism. The changes observed in muscles in hypothyroidism may be explained, at least in part, by changes in beta-adrenoceptor-G-protein-adenylate cyclase coupling affecting the generation of cyclic AMP and the regulation of some of the key enzymes of glycogen metabolism; in contrast, the changes observed in muscles in hyperthyroidism do not appear to result from alterations at the level of the receptor-mediated second-messenger generation.
Similar articles
-
Effects of the beta-adrenoceptor agonist isoprenaline on insulin-sensitivity in soleus muscle of the rat.Biochem J. 1986 Jan 15;233(2):377-81. doi: 10.1042/bj2330377. Biochem J. 1986. PMID: 3513763 Free PMC article.
-
Sensitivity of the soleus muscle to insulin in resting and exercising rats with experimental hypo- and hyper-thyroidism.Biochem J. 1989 Oct 1;263(1):243-7. doi: 10.1042/bj2630243. Biochem J. 1989. PMID: 2690814 Free PMC article.
-
Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.Br J Pharmacol. 1994 Mar;111(3):866-72. doi: 10.1111/j.1476-5381.1994.tb14818.x. Br J Pharmacol. 1994. PMID: 7912629 Free PMC article.
-
Gliclazide and insulin action in human muscle.Diabetes Res Clin Pract. 1991;14 Suppl 2:S61-4. doi: 10.1016/0168-8227(91)90009-3. Diabetes Res Clin Pract. 1991. PMID: 1794267 Review.
-
Beta-adrenergic agonists and hypertrophy of skeletal muscles.Life Sci. 1992;50(6):397-407. doi: 10.1016/0024-3205(92)90374-x. Life Sci. 1992. PMID: 1346465 Review.
Cited by
-
Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase.Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):231-5. Biochem J. 1999. PMID: 10548555 Free PMC article.
-
Insulin resistance and its correlation with chemerin and visfatin in Saudi patients with hyperthyroidism.Int J Health Sci (Qassim). 2019 Sep-Oct;13(5):18-21. Int J Health Sci (Qassim). 2019. PMID: 31501648 Free PMC article.
-
Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.PLoS One. 2012;7(10):e47936. doi: 10.1371/journal.pone.0047936. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094100 Free PMC article.
-
Smoothelin-Like Protein 1 Regulates Development and Metabolic Transformation of Skeletal Muscle in Hyperthyroidism.Front Endocrinol (Lausanne). 2021 Oct 5;12:751488. doi: 10.3389/fendo.2021.751488. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34675885 Free PMC article.
-
Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.J Pharmacol Exp Ther. 2010 Sep 1;334(3):795-808. doi: 10.1124/jpet.110.166009. Epub 2010 May 27. J Pharmacol Exp Ther. 2010. PMID: 20507928 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials